Skip to main content
. 2022 Feb 17;14(2):435. doi: 10.3390/pharmaceutics14020435

Table 1.

Half-maximal inhibitory concentrations (IC50) of Ag NPs against various human cancer cell lines.

Cancer Type Cell Line IC50 (μg/mL) Ref.
Liver cancer HepG2 48 [52]
HepG2 75 [53]
Breast cancer MCF-7 20 [55]
MCF-7 0.65 [56]
AU565 0.25 [56]
T47D 5 [57]
Ovarian cancer PA-1 30 [58]
A2780 7 [59]
A2780Cis 14.04 [59]
Prostate cancer PC-3 56.27 ± 1.17 [60]
Colon cancer HCT-116 50 [30]
HCT-116 1.152 [66]
HT29 4.88 [63]
Lung cancer A549 28 [58]
A549 11.28 ± 1.28 [60]
Bone cancer MG-63 0.665 [69]